GET DAILY SIGNALSSuperior Group of Companies (SGC): Analyst Targets Suggest +43% Upside Potential
Key Takeaways
- The central stock price target of $18 is the arithmetic mean of three verified analyst targets ($16, $18, and $20).
- With the stock near $12.60, reaching $18 implies roughly 43% upside — a substantial, not modest, move.
- The individual analyst range runs from a low of $16 (Noble Financial) to a high of $20 (Sidoti & Company).
- Key supports include accelerating branded-products growth, the Select VoiceCom acquisition, a refinanced balance sheet, and projected EPS (earnings per share) growth of roughly 42% in 2026.
- The biggest risk is an ongoing inventory- and credit-related restructuring in the Healthcare Apparel segment, plus small-cap volatility.
- Explore Major News, Today's Price Move, the Forecast, and Earnings pages for deeper coverage of this ticker.
- For a data-driven view, explore Trending AI Robots.
Analyst Consensus on SGC Price Targets
Superior Group of Companies, Inc. (SGC) designs and distributes branded uniforms, promotional products, healthcare apparel, and contact-center services. Three current analyst targets stand out. D.A. Davidson lifted its target to $18 from $15 with a Buy rating on August 5, 2026. Noble Financial held at $16 with a Buy the same day, while Sidoti & Company kept $20 in its September 17 update. The simple average of these three is $18, spanning $16 to $20.
The range is fairly narrow in dollar terms yet shows some divergence. Higher targets emphasize faster EPS growth and balance-sheet improvement, while the lower one takes a more cautious stance on near-term segment issues. No single target is a promise, and the mean remains a calculated figure rather than an official consensus.
Current Price and Path to the Target
Trading around $12.60, SGC would need to rise about 43% to hit $18. Third-quarter results showed 5% revenue growth to $146 million, driven by 8% in Branded Products and 7% in Contact Centers. Healthcare Apparel continued to face inventory and credit charges. Management narrowed full-year 2026 guidance to net sales of $578 million–$585 million and adjusted EPS of $0.60–$0.66, up from $0.46 in 2025. Reaching the target would likely hinge on stabilizing Healthcare Apparel while Branded Products momentum continues.
Factors That Could Support the Move Higher
- Branded Products momentum: the largest segment delivered 31% EBITDA growth alongside new customer wins and firmer pricing.
- Earnings growth: Street estimates call for roughly 42% EPS growth in 2026 and further double-digit gains in 2027, which could support a higher valuation multiple.
- Select VoiceCom acquisition: the Philippine contact-center transaction expands offshore reach and is expected to turn accretive starting in Q1 2027.
- Balance sheet: a refinanced $200 million credit facility, lower debt, and a dividend yield near 4% add flexibility.
Risks That Could Limit Upside
- Healthcare Apparel turnaround: management anticipates margin pressure through at least the first half of 2027 while streamlining the assortment.
- Valuation and size: as a micro-cap trading near 19x forward P/E, there is little room for execution slips.
- Macro sensitivity: demand in consumer-discretionary and employment-linked areas remains exposed to broader economic conditions and potential tariff shifts.
- Customer concentration: credit losses tied to one customer have already affected results.
Technical Levels Worth Watching
SGC’s 52-week range runs from roughly $8.30 to $14.59. The stock has recently traded near the upper end but pulled back after earnings. The zone around $14.50–$15 combines the 52-week high with a round-number resistance level and stands as a notable hurdle, with the $16, $18, and $20 targets above it. On the downside, the low-to-mid $11 area and the $8.30 low mark historical support.
Time Horizon and Items to Monitor
Analyst targets generally reflect a 12-month horizon, though Sidoti’s $20 target ties explicitly to its 2028 EPS estimate. I’m watching the Healthcare Apparel restructuring progress, Select VoiceCom integration and profitability, Branded Products growth and margins, and full-year 2027 guidance expected with fourth-quarter results. EPS revisions and any target changes after the next report will also indicate how views are evolving. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Final Assessment
The $18 central target is the arithmetic mean of three current analyst targets ($16–$20) and points to a substantial, roughly 43% advance from about $12.60. The bull case rests on accelerating Branded Products and Contact Centers growth, a projected sharp EPS rebound, and the accretive Select VoiceCom deal. The bear case centers on the unfinished Healthcare Apparel turnaround and the volatility typical of a small-cap, consumer-exposed business. Whether SGC reaches $18 depends on execution, and no analyst target should be viewed as a guaranteed outcome.
AI Daily Buy/Sell Signals
In my own research process, Tickeron’s AI Daily Buy/Sell Signals have become a useful complement. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions and technical patterns. For investors tracking SGC, it provides a systematic way to gauge when conditions may be turning, helping bridge fundamental analysis with real-time market signals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SGC in upward trend: 10-day moving average broke above 50-day moving average on October 02, 2026
The 10-day moving average for SGC crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SGC as a result. In 89 of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for SGC just turned positive on November 04, 2026. Looking at past instances where SGC's MACD turned positive, the stock continued to rise in 34 of 52 cases over the following month. The odds of a continued upward trend are 65%.
SGC moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGC advanced for three days, in 190 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 173 of 209 cases where SGC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
SGC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. SGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 51 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.108) is normal, around the industry mean (2.911). P/E Ratio (24.000) is within average values for comparable stocks, (14.016). Projected Growth (PEG Ratio) (1.418) is also within normal values, averaging (0.686). Dividend Yield (0.042) settles around the average of (0.328) among similar stocks. P/S Ratio (0.326) is also within normal values, averaging (0.827).
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of employee uniforms, image apparel, scrubs and patient apparel
Industry ApparelFootwear
Advertisement